StockNews.com upgraded shares of Inovio Pharmaceuticals (NASDAQ:INO – Free Report) from a sell rating to a hold rating in a report released on Thursday morning. INO has been the topic of several other research reports. JMP Securities began coverage on Inovio Pharmaceuticals in a research report on Thursday, January 4th. They set a market outperform […]